Abcam plc (ABCZF PINK) stock market data APIs
$22.0486
0(0%)
as of April 17, 2025
Abcam plc Financial Data Overview
Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.
Prev. Close
22.0486
Open
22.0486
High
22.0486
Low
22.0486
52 wk Range
22.25-22.25
Market Cap
5 121 M
P/E Ratio
2225
Shares Outstanding
230 M
Revenue
380 M
EPS
0.0135
Beta
0.863
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Abcam plc data using free add-ons & libraries
Get Abcam plc Fundamental Data
Abcam plc Fundamental data includes:
- Net Revenue: 380 M
- EBITDA: 106 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Abcam plc News
New
Danaher (DHR) Acquires Abcam to Boost Life Sciences Segment
Danaher Corporation DHR has completed the acquisition of Cambridge, UK-based Abcam plc for $24.00 per share in cash. The deal, valued at approximately $5.7 billion (including assumed indebtedness and ...
UPDATE 1-Danaher completes $5.7 billion acquisition of Abcam
(Adds details on background in paragraphs 2-5) Dec 6 (Reuters) - Medical tools supplier Danaher said on Wednesday it has completed the $5.7 billion acquisition of Abcam, overcoming the initial opposi...
Danaher Completes Acquisition of Abcam
WASHINGTON, Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for...
Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales
CAMBRIDGE, England & WALTHAM, Mass., December 04, 2023--(BUSINESS WIRE)--Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science res...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
